What Is FDA 21 CFR Part 11?
FDA 21 CFR Part 11 is the federal regulation that governs electronic records and electronic signatures in pharmaceutical, biotech, and medical device environments. It applies to clinical trials, R&D systems, and manufacturing platforms. Any system that creates, modifies, or archives regulated data falls under its scope. AdVran sets up and maintains the technical controls these environments require.
Why Choose AdVran for 21 CFR Part 11?
FDA-regulated organizations using electronic records and signatures must show that their systems are validated, secure, and maintain data integrity across the full record lifecycle. That’s not a one-time project. It’s an ongoing operational commitment that touches your IT infrastructure daily.
1. System Validation Support
We keep the IT infrastructure under validated systems in a qualified state. That means documented configurations, change controls, and operating procedures that hold up under FDA scrutiny. (Which is harder than it sounds when your systems are constantly changing.)
2. Access Controls and Audit Trails
Part 11 requires unique user identification, secure authentication, and computer-generated, timestamped audit trails. We set up and monitor these controls across all regulated systems, not just the ones you think are in scope.
3. Electronic Signature Controls
We make sure electronic signature systems meet Part 11 requirements: signatures are bound to records, repudiation is blocked, and signature integrity is maintained throughout the retention period. No gaps, no workarounds.
4. Data Integrity (ALCOA+)
Our infrastructure controls support the ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available. Data integrity gets built into how the systems operate from day one, not bolted on after an audit finding.
5. Change Control for Regulated Systems
Every change to systems in Part 11 scope follows a validated change control process with impact assessment, testing documentation, and approval workflows. This satisfies FDA expectations and keeps your IT team from becoming a compliance liability.
Frequently Asked Questions About FDA 21 CFR Part 11 Compliance
Who must comply with this regulation?
This regulation applies to healthcare providers, health plans, pharmaceutical companies, medical device manufacturers, and their technology service providers operating in California and nationally. Southern California’s large healthcare sector, including hospital systems across Los Angeles County, Orange County, and San Diego, makes this framework broadly applicable across the region.
What are the primary compliance requirements?
Requirements include data protection controls, access management for sensitive health or life sciences data, audit logging, incident response procedures, and documented risk assessments. AdVran sets up the technical controls this framework requires and collects evidence continuously, so clients stay audit-ready without scrambling before each inspection.
What are the penalties for non-compliance?
Penalties can include significant civil monetary penalties from federal agencies such as HHS OCR or the FDA, state enforcement actions by the California Department of Public Health, private litigation, and reputational damage. Healthcare organizations increasingly face combined federal and California-level enforcement exposure.
How does AdVran support compliance in healthcare environments?
AdVran offers HIPAA-aligned managed IT and security services, with added framework expertise for life sciences, pharmaceutical, and medical device clients. Our team works regularly with the specific technology environments common in Southern California’s healthcare and biotech sectors: EHRs, laboratory systems, medical devices, and research platforms.
- GDPR/CCPA — electronic data records and privacy overlap
How does this framework interact with HIPAA and other healthcare regulations?
Many healthcare compliance frameworks overlap significantly. Rather than building separate programs for each requirement, organizations can build one integrated program. AdVran’s multi-framework approach maps controls across HIPAA, Part 11, and applicable state requirements at the same time, cutting down on duplicated effort and redundant evidence collection.